The heart pump devices market will grow at a rate of 22.1% by the end of this decade, to touch USD 10,912.6 million by 2030. This is because of the rising cardiovascular ailment incidence, growing elderly population, and numerous novel product introductions by market players.
On the basis of the product, VADs has the largest share, of about 70%, on account of the growing rate of tech progressions in these products by the industry players and the unreachability of organ donors. The vital drivers are the increasing number of patients suffering from heart failure and the long waiting for surgeries.
On the basis of type, the implanted category has a larger share. This is as a result of the improved eminence of life and longer survival post heart transplant these alternatives offer and the launches of the product by players.
The BTT category will have the fastest growth in the years to come. This is because of the increasing consciousness of transplantation and the obtainability of LVADs for bridge-to-transplant procedures.
North America heart pump devices market had the largest share, of around 45%, in 2022. This is because of the increasing requirement for tech advanced cardiac assist devices because of the snowballing prevalence of cardiovascular ailments. In Canada, as per the government statistics, heart disease is the second- foremost cause of death post cancer, with about 67,400 people in the country dying because of these issues in 2020.
It is because of the growing elderly population all over the world, the demand for heart pump devices will continue to increase in the years to come.